Project Grant HT9425261E243
Award Date 7/1/26
Completion Date 6/30/30
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded UCLA a $2.16M Project Grant on September 30, 2025, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on cerebellar neuromodulation to reduce cognitive dysfunction after multiple subconcussive impacts. The four-year project, scheduled for completion on September 29, 2029, will be performed at UCLA's Los Angeles campus through the Office of Research Administration. This award supports...
- Federal Grant Award Summary The University of California, Los Angeles (UCLA) received a $799,999 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2026, through April 30, 2030. The project, titled "From H&E to HRD: Linking Morphometry, Clinical, and Molecular Data for Drug Response Prediction," involves the development of integrated analytical methodologies and data systems that combine...
- This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
- Federal Grant Award Summary The University of California, Los Angeles (UCLA) received a $551,216 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2027. The grant funds research to elucidate the functional role of PPP1R1B-lncRNA in myocyte repair in Duchenne muscular dystrophy (DMD). This research initiative represents a hypothesis-driven investigation into therapeutic...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of California, Los Angeles (UCLA) a Project Grant totaling $7.35 million on August 1, 2025, under the Military Medical Research and Development program (CFDA 12.420) to conduct a clinical evaluation of 4-aminopyridine in hereditary spinocerebellar ataxia. The two-year award, with a completion date of July 31, 2027, supports research conducted at UCLA's Los Angeles campus through the institution's Office of...
- The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a four-year $596,016 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCLA's research into "ENVIRONMENTAL AND GUT-BRAIN AXIS DETERMINANTS OF COGNITIVE OUTCOMES IN PD" from September 1, 2023 through August 31, 2027. As the prime awardee, UCLA will leverage its research expertise and...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $235,476 project grant to the University of California, Los Angeles (UCLA) Office of Research Administration on November 1, 2025, to develop new cell-mediated immunotherapeutic strategies for neuroendocrine prostate cancer. The two-year award, which concludes October 31, 2027, is funded under the Military Medical Research and Development program (CFDA 12.420) and will be conducted at UCLA's Los Angeles, California facility....
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded UCLA a $700,000 project grant on June 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support early detection of ovarian cancer through cell-free DNA (cfDNA) methylome sequencing and protein biomarkers research. The four-year project, concluding May 31, 2030, will be conducted at UCLA's Los Angeles facility through the Office of Research Administration. This award represents DHA's investment...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded UCLA a $739,332 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop a machine learning approach using patient registry data to identify and reveal neurological manifestations of persistent Lyme disease. The three-year award, effective June 1, 2025, through May 31, 2028, will be performed at UCLA's Los Angeles, California location. This research initiative leverages advanced...
- Federal Project Grant Award Summary The Defense Health Agency (DHA), through its Military Medical Research and Development program (CFDA 12.420), awarded a $157,500 Project Grant to the University of California, Los Angeles (UCLA) Office of Research Administration, effective September 1, 2025, with completion scheduled for August 31, 2026. The award supports research investigating the impact of a hypomorphic SMARCB1 germline allele specific for schwannomatosis on mouse development and...